Evidence map›Paper›PMID 26104972›Full record

Observational studyOrphanet journal of rare diseases2015

Diffuse left ventricular interstitial fibrosis is associated with sub-clinical myocardial dysfunction in Alström Syndrome: an observational study.

Nicola C Edwards, William E Moody, Mengshi Yuan, Adrian T Warfield, Robert Cramb, Richard B Paisey, Tarekegn Geberhiwot, Richard P Steeds

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Orphanet journal of rare diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 3 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Obesity-Related Ciliopathies: Focus on Advances of Biomarkers.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Nicola C EdwardsSchool of Clinical and Experimental Medicine, University of Birmingham, Birmingham, UK. n.c.edwards@bham.ac.uk.
William E MoodySchool of Clinical and Experimental Medicine, University of Birmingham, Birmingham, UK.
Mengshi YuanSchool of Clinical and Experimental Medicine, University of Birmingham, Birmingham, UK.
Adrian T WarfieldDepartment of Pathology, Queen Elizabeth Hospital, Birmingham, England.
Robert CrambDepartment of Biochemistry, Queen Elizabeth Hospital, Birmingham, UK.
Richard B PaiseyDepartment of Diabetes, Torbay Hospital, Torbay, UK.
Tarekegn GeberhiwotDepartment of Endocrinology, Queen Elizabeth Hospital, Birmingham, UK.
Richard P SteedsSchool of Clinical and Experimental Medicine, University of Birmingham, Birmingham, UK.
Queen Elizabeth Hospital Birmingham · GBTorbay Hospital · GBUniversity of Birmingham · GB

Funding

British Heart Foundation FS/11/17/28700
6 · The paper itself

Abstract

backgroundAlström syndrome is a rare inherited ciliopathy with progressive multisystem involvement. Dilated cardiomyopathy is common in infancy and recurs or presents de novo in adults with high rates of premature cardiovascular death. Although Alström syndrome is characterised by fibrosis in solid organs such as the liver, the pathogenesis of related cardiomyopathy are not clear. To date it is not known whether diffuse interstitial myocardial fibrosis is present before the onset of heart failure symptoms or changes in conventional parameters of left ventricular function.

methodsIn this observational study, 26 patients with Alström syndrome (mean age 27 ± 9 years, 65 % male, 24 h ABPM 130 ± 14 / 77 ± 9 mmHg) without symptomatic cardiovascular disease were recruited from a single centre and compared to matched healthy controls. All subjects underwent cardiac MRI (1.5 T) to assess ventricular function, diffuse interstitial myocardial fibrosis by measurement of extracellular volume on T1-mapping (MOLLI) and coarse replacement fibrosis using standard late gadolinium enhancement imaging.

resultsGlobal extracellular volume was increased in Alström syndrome with wider variation compared to controls (0.30 ± 0.05 vs. 0.25 ± 0.01, p < 0.05). Left ventricular long axis function and global longitudinal strain were impaired in Alström syndrome without change in ejection fraction, ventricular size or atrial stress (NT-proBNP) (p < 0.05). Global extracellular volume was associated with reduced peak systolic longitudinal strain (r = -0.73, p < 0.01) and strain rate (r = -0.57, p < 0.01), increased QTc interval (r = 0.49, p < 0.05) and serum triglycerides (r = 0.66, p < 0.01). Nine (35 %) patients had diffuse mid-wall late gadolinium enhancement in a non-coronary artery distribution.

conclusionDiffuse interstitial myocardial fibrosis is common in Alström syndrome and is associated with impaired left ventricular systolic function. Serial studies are required to determine whether global extracellular volume may be an independent imaging biomarker of vulnerability to dilated cardiomyopathy and heart failure.

Indexed as

AdolescentAdultAlstrom SyndromeCardiomyopathiesFemaleHeart VentriclesHumansMagnetic Resonance ImagingMaleVentricular Function, LeftYoung Adult

Identifiers

PMID26104972
PMCPMC4483224
OpenAlexW2117885682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.